세계의 단일 세포 분석 시장 보고서(2025년)
Single-cell Analysis Global Market Report 2025
상품코드 : 1807769
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단일 세포 분석 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에 CAGR은 15.7%를 나타낼 것으로 예측되고 70억 5,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 적용 범위 확대, 임상 진단 분야에서의 채택 증가, 데이터 분석 기술 발전에 기인할 수 있습니다. 예측 기간의 주요 트렌드로는 협력 및 파트너십, 다중 오믹스 통합, 단일 세포 공간 분석, 자동화 및 고처리량 기술, 인공지능(AI) 및 머신러닝 통합, 신경학 분야에서의 응용 확대 등이 있습니다.

향후 5년간 15.7% 성장이라는 예측치는 이 시장에 대한 이전 추정치 대비 0.1% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 다른 국가들 간의 관세 영향 때문입니다. 관세 부과로 독일 및 싱가포르에서 수입되는 미세유체 세포 분류기 및 게놈 시퀀싱 시약의 비용이 증가하여 미국 생물의학 연구가 차질을 빚을 수 있으며, 정밀의학 발전 속도가 둔화되고 실험실 운영 비용이 상승할 가능성이 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.

전 세계적으로 맞춤형 의학에 대한 강조가 높아지면서 단일 세포 분석 시장이 확대되고 있습니다. 맞춤형 의학은 개인의 유전적 프로필을 활용하여 해당 개인에게 특화된 질병의 치료, 예방 및 진단에 관한 결정을 내리는 의료 접근법입니다. 단일 세포 분석은 개별 환자의 요구 사항, 질병의 특성 및 맞춤형 치료 옵션에 대한 상세한 인사이트을 제공함으로써 다양한 질환 치료에 중요한 역할을 합니다. 그 결과 더 많은 환자들이 치료를 위해 맞춤형 의학을 선택하고 있습니다. 예를 들어, 2024년 2월 미국 비영리 단체인 맞춤형 의학 연합(Personalized Medicine Coalition)은 FDA가 2023년에 희귀 질환 환자를 위한 16개의 새로운 맞춤형 치료법을 승인했다고 보고했는데, 이는 2022년의 6개에 비해 증가한 수치입니다. 따라서 맞춤형 의학에 대한 관심이 높아지면서 시장 성장이 촉진되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

HBR
영문 목차

영문목차

Single-cell analysis involves the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the individual cell level. This field aids in standardizing and automating workflows to gather information crucial for treating various diseases, including cancer. Activities in single-cell analysis revolve around research and experimental development in this specialized area.

The primary categories of single-cell analysis include consumables and instruments. Consumables are employed in tasks such as exosome analysis, genetic exploration, and isolation of RNA and DNA. The workflow of single-cell analysis comprises single-cell isolation and library preparation, downstream analysis, and data analysis. Techniques utilized in this process encompass flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, among others. Single-cell analysis finds applications in diverse areas such as cancer research, immunology, neurology, stem cell studies, non-invasive prenatal diagnosis, in-vitro fertilization, and more. The end-users of single-cell analysis include academic and research laboratories, biotechnology and pharmaceutical companies, as well as hospital and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are taking a toll on the professional services sector, especially within legal, consulting, architectural, and engineering fields. Increased duties on imported technology, software, office hardware, and digital infrastructure have pushed up operational costs for firms that rely on global systems and resources. Cross-border consulting engagements are experiencing delays and higher expenses due to elevated travel costs and limited access to international data and tools. Moreover, industries heavily impacted by tariffs such as manufacturing, construction, and logistics are reducing their reliance on outsourced services, dampening demand for professional support. In response, service providers are reassessing pricing models, strengthening ties with domestic vendors, and accelerating the adoption of AI and automation to maintain profitability and client satisfaction in an increasingly volatile environment.

The single-cell analysis market research report is one of a series of new reports from The Business Research Company that provides single-cell analysis market statistics, including single-cell analysis industry global market size, regional shares, competitors with a single-cell analysis market share, detailed single-cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis industry. This single-cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell analysis market size has grown rapidly in recent years. It will grow from $3.5 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to rising research in genomics, increased funding, biopharmaceutical R&D.

The single-cell analysis market size is expected to see rapid growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to wider application scope, rising adoption in clinical diagnostics, advancements in data analysis. Major trends in the forecast period include collaborations and partnerships, multi-omics integration, single-cell spatial analysis, automation and high-throughput technologies, ai and machine learning integration, expanding applications in neurology.

The forecast of 15.7% growth over the next five years reflects a modest reduction of 0.1% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. biomedical research by increasing costs for microfluidic cell sorters and genomic sequencing reagents imported from Germany and Singapore, potentially slowing precision medicine advancements while raising laboratory operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising emphasis on personalized medicine worldwide is driving the expansion of the single-cell analysis market. Personalized medicine is a medical approach that utilizes an individual's genetic profile to inform decisions regarding the treatment, prevention, and diagnosis of diseases specific to that person. Single-cell analysis plays a crucial role in treating various conditions by providing detailed insights into individual patient needs, the nature of the disease, and tailored treatment options. As a result, more patients are choosing personalized medicine for their care. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the growing focus on personalized medicine is fueling market growth.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the single-cell analysis market in the foreseeable future. Chronic diseases, characterized by prolonged durations and lack of preventative or vaccination-based treatment, benefit from the insights provided by single-cell analysis. This approach enables a deeper understanding of the pathophysiology of chronic illnesses, paving the way for more tailored and effective treatment options. For instance, as of March 2022, the Australian Bureau of Statistics reported that over three-quarters of Australians (78. 6%) had at least one long-term health problem, with nearly half (46. 6% or 11. 6 million) dealing with at least one chronic ailment. Thus, the increasing prevalence of chronic diseases is a driving force behind the growth of the single-cell analysis market.

Companies in the single-cell analysis market are prioritizing clinical diagnostic products like the ddSEQ Single-Cell 3' RNA-Seq Kit to support high-quality single-cell RNA sequencing. The ddSEQ Single-Cell 3' RNA-Seq Kit is specifically designed for precise RNA sequencing, offering detailed insights into gene expression within individual cells. For instance, in June 2024, Bio-Rad, a US-based global leader in life science research and clinical diagnostics, introduced the Single-Cell 3' RNA-Seq Kit for single-cell gene expression. This specialized kit is tailored for high-throughput sequencing of gene expression in individual cells, focusing on capturing the 3' end of mRNA transcripts. It allows researchers to analyze and quantify gene expression profiles at the single-cell level, making it a valuable tool in studies of cellular heterogeneity, developmental biology, and disease mechanisms. This kit provides critical insights into complex biological systems, further advancing the single-cell analysis market.

Major players in the single-cell analysis market are committed to developing innovative products to better serve their existing consumer base. In December 2022, Scale Biosciences Inc. launched ScaleBio's scRNAseq solution, utilizing the company's proprietary combinatorial indexing technology. This solution allows for the scanning of up to 96 samples and thousands of cells in a single study, at a cost significantly lower than existing single-cell systems. The scRNAseq solution is designed for the characterization of cell lines, PBMCs, and nuclei, providing a fixation kit for sample fixation, storage, and transport.

In July 2023, Illumina, Inc., a US-based biotechnology company, acquired Fluent BioSciences for an undisclosed amount. The purpose of this acquisition is to enhance Illumina's capabilities in single-cell analysis and expand its multiomics growth strategy by integrating Fluent BioSciences' innovative and accessible technology. Fluent BioSciences, also based in the US, focuses on advancing technologies for single-cell analysis, with a particular emphasis on creating scalable and innovative solutions that facilitate genomic research and enable researchers to conduct detailed studies at the single-cell level.

Major companies operating in the single-cell analysis market include Becton Dickinson and Company, Merck KGAA, QIAGEN N. V., Thermo Fisher Scientific Inc., Illumina Inc., Standard BioTools Inc., 10X Genomics Inc., Bio-Rad Laboratories Inc., Novogene Corporation Limited, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences Inc., Oxford Nanopore Technologies Ltd., 1CellBio Inc., 3D Biomatrix Inc., ACEA Biosciences Inc., Akoya Biosciences Inc., Berkeley Lights Inc., Bio-Techne Corporation, Celsee Inc., Cellular Research Inc., Cytena GmbH, Dolomite Bio Limited, Drop-seq Technologies Inc., Epic Sciences Inc., Ginkgo Bioworks Inc., IsoPlexis Corporation, Menarini Silicon Biosystems S. p. A., Mission Bio Inc., NanoCellect Biomedical Inc., NemaMetrix Inc., OnRamp Bioinformatics Inc., Partek Incorporated, RareCyte Inc., Scienion AG, SeqWell Inc., Sphere Fluidics Limited, Takara Bio USA Holdings Inc.

North America was the largest region in the single-cell analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The single-cell analysis market includes revenues earned by entities by providing services such as antibody-based methods, fluorescent protein-based methods, and mass-spectroscopy based methods. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-cell Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for single-cell analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Single-Cell Analysis Market Characteristics

3. Single-Cell Analysis Market Trends And Strategies

4. Single-Cell Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Single-Cell Analysis Growth Analysis And Strategic Analysis Framework

6. Single-Cell Analysis Market Segmentation

7. Single-Cell Analysis Market Regional And Country Analysis

8. Asia-Pacific Single-Cell Analysis Market

9. China Single-Cell Analysis Market

10. India Single-Cell Analysis Market

11. Japan Single-Cell Analysis Market

12. Australia Single-Cell Analysis Market

13. Indonesia Single-Cell Analysis Market

14. South Korea Single-Cell Analysis Market

15. Western Europe Single-Cell Analysis Market

16. UK Single-Cell Analysis Market

17. Germany Single-Cell Analysis Market

18. France Single-Cell Analysis Market

19. Italy Single-Cell Analysis Market

20. Spain Single-Cell Analysis Market

21. Eastern Europe Single-Cell Analysis Market

22. Russia Single-Cell Analysis Market

23. North America Single-Cell Analysis Market

24. USA Single-Cell Analysis Market

25. Canada Single-Cell Analysis Market

26. South America Single-Cell Analysis Market

27. Brazil Single-Cell Analysis Market

28. Middle East Single-Cell Analysis Market

29. Africa Single-Cell Analysis Market

30. Single-Cell Analysis Market Competitive Landscape And Company Profiles

31. Single-Cell Analysis Market Other Major And Innovative Companies

32. Global Single-Cell Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single-Cell Analysis Market

34. Recent Developments In The Single-Cell Analysis Market

35. Single-Cell Analysis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기